Vaidya Sane Ayurved Laboratories Ltd

Vaidya Sane Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vaidya Sane Ayurved Laboratories Ltd

₹ 200 3.39%
22 May - close price
madhavbaug.org NSE - SME: MADHAVBAUG
About

Incorporated in 2006, Vaidya Sane Ayurved Laboratories Ltd is the business of running
of hospitals & clinics, and sale of Ayurved based medicines[1]

Key Points

Business Overview[1]
Vaidya Sane Ayurved Laboratories Ltd (Madhavbaug) is among India’s leading chains of cardiac care clinics and hospitals, specializing in non-invasive, Ayurveda-based treatments for chronic conditions like heart disease, diabetes, hypertension, obesity, and joint pain. The company combines traditional medicine with modern diagnostics and technology, supported by in-house manufacturing of Ayurvedic medicines and nutritional products.

Website NSE - SM
  • Market Cap ₹ 210 Cr.
  • Current Price ₹ 200
  • High / Low ₹ 335 / 140
  • Stock P/E 23.4
  • Book Value ₹ 83.2
  • Dividend Yield 0.00 %
  • ROCE 15.1 %
  • ROE 12.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 10.2% over last 3 years.
  • Working capital days have increased from 41.3 days to 112 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Part of Nifty SME Emerge

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
46 54 51 48 42 48 50 57
41 50 48 46 36 40 41 50
Operating Profit 4 4 3 2 6 9 9 7
OPM % 9% 7% 5% 4% 14% 18% 17% 12%
1 1 1 1 1 -0 1 1
Interest 0 0 0 0 0 1 0 1
Depreciation 1 1 2 2 2 2 3 3
Profit before tax 4 3 2 1 5 5 6 4
Tax % 27% 23% 25% 37% 21% 34% 25% 4%
3 2 1 1 4 3 5 4
EPS in Rs 2.60 1.99 1.12 0.76 3.58 3.21 4.59 3.96
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
99 99 90 107
91 95 76 91
Operating Profit 9 5 13 15
OPM % 9% 5% 15% 14%
1 2 1 2
Interest 1 0 0 1
Depreciation 3 3 4 6
Profit before tax 6 3 10 11
Tax % 25% 30% 28% 17%
5 2 7 9
EPS in Rs 4.59 1.88 6.80 8.55
Dividend Payout % 5% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 3%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 23%
TTM: 12%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -7%
1 Year: 39%
Return on Equity
10 Years: %
5 Years: %
3 Years: 10%
Last Year: 12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 11 11 11 11
Reserves 30 45 52 77
0 2 1 3
14 12 13 14
Total Liabilities 55 70 77 105
21 28 34 35
CWIP 2 2 1 2
Investments 15 18 21 40
17 21 20 28
Total Assets 55 70 77 105

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
0 -1 11 5
1 -13 -10 -24
-1 15 -1 17
Net Cash Flow -1 1 -0 -2
Free Cash Flow -7 -12 2 -2
CFO/OP 31% -9% 93% 49%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 22 22 31 35
Inventory Days 58 82 70
Days Payable 101 149 127
Cash Conversion Cycle 22 -20 -37 -21
Working Capital Days -2 5 7 112
ROCE % 6% 18% 15%

Insights

In beta
Dec 2006 Dec 2013 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
EBITDA Margin
%

Log in to view insights

Please log in to see hidden values.

Login
Number of Clinics (Total Network)
Number
Average Revenue per Clinic (Enterprise)
INR Lacs
Number of Hospitals
Number
Total Patient Footfall
Number
New Patient Footfall
Number
Research Papers Published
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Sep 2024Mar 2025Sep 2025Dec 2025Mar 2026
66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34% 66.34%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.21% 0.00% 0.00%
33.66% 33.68% 33.67% 33.67% 33.66% 33.66% 33.66% 33.66% 33.66% 33.45% 33.66% 33.66%
No. of Shareholders 464534595637731846881821787712700671

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls